TNFRSF11B and Hyperglycemia: On the one hand, hyperglycemia and increased inflammation lead to an increase in receptor activator of nuclear factor κB ligand (RANKL) and a decrease in osteoprotegerin (OPG), which contribute to greater bone resorption (11, 12).